“We found that for women, poor sleep is strongly associated with high levels of psychological distress, and greater feelings of hostility, depression and anger,” said researcher Suarez. Men experiencing the same degree of poor sleep did not have this reaction.

The sleep indicator that suggested to be most impactful was the amount of time it took to fall asleep. Those who took 30 minutes or longer to fall asleep had the worst risk profile for diseases such as heart disease and diabetes.

As new as this information may seem, the study was conducted in 2008. Since then, numerous studies have delved deeper into the negative effects poor sleep has on health. Poor sleep affects not only heart health and insulin levels, but it also impacts memory, stress levels, weight gain, and other body functions. Calling to attention that it is women who are most affected by poor sleep, it is even more important for them to make a conscious effort to improve their sleep situations.

For those who have trouble falling asleep at night, an all-natural dietary supplement such as Seditol® may help. Seditol has the capability to help people fall asleep faster and stay asleep longer without side effects or “hangover” the next morning.

A group of 123,775 men, aged 45 years and older were selected at random. The results showed that the risk of cardiovascular disease increased consistently with the severity of ED. Furthermore, men with severe erectile dysfunction and no previous diagnoses of CVD had an increased risk of ischemic heart disease, heart failure, peripheral vascular disease, and a 93% increased risk of all-cause mortality.

Although arterial, hormonal, psychological, and other causes for ED exist, it is now widely believed that ED is most often due to cardiovascular health. Scientists emphasize that ED is a risk marker for CVD, neither a symptom nor cause of it. Hypotheses suggest that the reason for ED being a marker of cardiovascular health is that the atherosclerotic disease may first manifest in smaller blood vessels, such as those in the penis.

Flavoxine is an all-natural supplement that supports cardiovascular health and weight management ideal for those looking for a natural solution for heart health.

The short-term studies suggested that sleep deprivation impairs glucose tolerance and overall energy, while increasing insulin resistance and appetite. The effect of sleep deprivation on insulin sensitivity was significant, showing a 30% reduction in peripheral insulin sensitivity. If continued over a long period, it is believed that it may be linked to the development of diabetes and obesity.

The results of the study lead researchers to believe that further studies on sleep deprivation may show that it also plays a role in other diseases, including cancer.

For those who struggle with restful sleep, Seditol® is an all-natural alternative that has the capability to help people fall asleep faster and stay asleep longer without feeling groggy or “hungover” the next morning.

Entitled F as in Fat: How Obesity Threatens America’s Future 2012, highlights from the projected statistics given current trends include the following:
• The number of new cases of type 2 diabetes, coronary heart disease and stroke, hypertension and arthritis could increase 10 times between 2010 and 2020-and double again by 2030.
• Medical costs of treating preventable obesity-related diseases will increase $18 billion per year in the US with the overall cost of adult obesity estimated to be as high as $210 billion per year.
• The percentage of obese individuals will almost double in many states across the country, hitting as high as 66% in Mississippi and Oklahoma.

According to the study, even reductions as little as 5% in Body Mass Index (BMI) would spare, in California alone, 656,970 people from coronary heart disease and stroke, 796,430 people from Type 2 diabetes, 387,850 from arthritis and 52,796 from obesity-related cancer.

Exercise, health diet, good sleep and low stress levels are all contributors to a healthy lifestyle. Relora® for stress and weight loss management and Seditol® for restful sleep may help those looking to improve their overall health and beat the projections of obesity in the coming years.

The study found that parent stress is directly related to child obesity. The number one behavior correlated to parental stress was fast-food consumption, an indicator of obesity risk. According to one psychologist at Children’s National Medical Center in Washington, D.C., “We do see this in clinical practice. Parents are often stressed and have a hard time providing healthy options”. This can be due to financial and/or time pressures.

Within the study findings, a few demographic groups suggested to be more susceptible to the parent stress-child obesity link: children from single-parent households, children from families struggling financially, and black/Hispanic children.

Relora® may be an option for parents looking to decrease stress levels naturally when time is not available to exercise and take time out for themselves. With the findings linking parental stress and childhood obesity, stress management becomes a priority not only for parents’ own health, but for their children’s health as well.

The study, conducted at the Universitario San Carlos in Madrid, Spain, examined 450 individuals with an average age of 54. Though younger than the average stroke victim, the target age was selected because high blood pressure and other health issues related to stroke often have not yet taken affect.

The study unveiled a number of findings related to stress and stroke. First, the study concluded that that chronic stress and type A behavior are associated with high risk of stroke and may increase the risk of stroke up to 200%. This is not affected by gender. Secondly, other factors that may increase the risk of stroke may include a history of smoking or drinking two or more energy drinks a day, the latter of which came as a surprise to researchers.

According to researcher Ana Maria Garcia, “Our findings indicate that people can lower their stroke risk by attempting to reduce the stress in their lives”. The research suggests yet another critical reason to control stress levels. Relora®, an all-natural dietary supplement to alleviate stress, is one of the top products in its category and the most powerful anti-stress supplement on the market.

The researchers hypothesized that people with highly fatty diets may produce less CD36 protein, making them less sensitive to fatty foods and, consequently, more likely to intake fat.

The research-the first of its kind to identify a human receptor that can taste fat-appears to support previous findings that obesity is linked to genes as well as a person’s diet. The study also found that nearly 20 percent of Americans are likely to produce less CD36 and are therefore less sensitive to the taste of fatty foods.

People who suffer from obesity are at an elevated risk for cardiovascular disease, stroke, diabetes, and arthritis. Relora, an all-natural blend of Magnolia officinalis bark extract and Phellodendron amurense bark extract, is the leading all-natural dietary supplement to alleviate stress, stress-related eating and promote weight management.

The study indicated that those surveyed were more likely to report making administrative errors, fall asleep while driving, express anger toward citizens or suspects, and commit safety violations as a result of their sleeping disorders. Police departments nationwide have responded by lowering shift hours and initiated other regulations intended to address reported symptoms.

According to the findings, an estimated 50 to 70 million Americans suffer from sleep disorders, including sleep apnea or insomnia, and most who suffer are undiagnosed. Along with a healthy diet, reassessment of shift conditions, and professional medical advice, persons suffering from a sleep disorders may consider all-natural dietary supplements, such as Seditol®, which has been shown through multiple clinical trials to promote relaxation and sleep.

The study findings will be useful to scientists who are developing new drug treatments for PRMT1-related ailments and for targeting specific enzymes in the human body. It also moves scientists one step closer to identifying the enzyme responsible for nearly all arginine methylation present in mammalian cells.

To date scientists have been unable to distinguish between compounds inhibiting PRMT1 and those blocking the larger PRMT family of enzymes. This was largely due to the fact that scientists could not distinguish between PRMT1 and the 10 other PRMT enzymes due to their structural and biochemical similarities.

As research continues to explore the link between the development of these enzymes and inflammation, individuals suffering from symptoms relating to inflammation seek out remedies to alleviate their pain. There are currently countless prescription anti-inflammatories available on the market as well as a few supplements.

Nexrutine, an all-natural dietary supplement produced from the proprietary blend of actives extracted from the bark of Phellodendron amurense, acts to inhibit enzymes related to inflammation and is shown to safely and effectively help avoid or relieve the general aches and pains associated with physical activity or over-exertion.

Twenty beagle dogs in good health and between 4 and 8 years old were selected for the study. Thunderstorm sounds were reproduced using a sound desensitization compact disc shown to be effective for behavior modification programs for noise-related anxieties. The beagles were video recorded for 9 minutes: a 3 minute anticipatory phase, a 3 min. thunderstorm phase and a 3 min. recovery phase.

One group received the placebo during the first treatment period and the other received Harmonease. On day 13, dogs were again subjected to the thunderstorm testing and the treatment groups were crossed over so that dogs receiving Harmonease during the first treatment period received the placebo during the second treatment period and vice versa.

The model measured stress-related clinical signs during the test such as distance travelled by the dog, inactivity duration and inactivity frequency – all related to freezing responses and the most robust measures of anxiety in this test.

The test facility was operated in accordance with guidelines set forth by the Canadian Council on Animal Care. Animal housing and care met or exceeded all applicable provincial and Federal regulations, and the study protocol was approved by the test facility’s Animal Care Committee.

Sixty percent (60%) of dogs improved from baseline when treated with Harmonease, whereas only 25% improved on placebo. Furthermore, Harmonease has a comparatively low risk of producing side effects such as central depression, muscle relaxation, or amnesia as compared to benzodiazepines, commonly used to address anxiety in dogs.

The study concluded that Harmonease reduced fear-related inactivity or freezing in dogs in this thunderstorm simulation model. This supports past studies demonstrating that the combination of botanical extracts in Harmonease is effective in dogs for the management of stress-related behaviors.